These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28095679)

  • 41. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
    Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
    Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.
    Vuillemenot BR; Korte S; Wright TL; Adams EL; Boyd RB; Butt MT
    Toxicol Sci; 2016 Jul; 152(1):3-9. PubMed ID: 27354708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The microtubule-stabilizing drug Epothilone D increases axonal sprouting following transection injury in vitro.
    Brizuela M; Blizzard CA; Chuckowree JA; Dawkins E; Gasperini RJ; Young KM; Dickson TC
    Mol Cell Neurosci; 2015 May; 66(Pt B):129-40. PubMed ID: 25684676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microtubule-targeting agents and neurodegeneration.
    Boiarska Z; Passarella D
    Drug Discov Today; 2021 Feb; 26(2):604-615. PubMed ID: 33279455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microglial cells in neurodegenerative disorders.
    Wojtera M; Sikorska B; Sobow T; Liberski PP
    Folia Neuropathol; 2005; 43(4):311-21. PubMed ID: 16416395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.
    Calsolaro V; Edison P
    CNS Drugs; 2015 Dec; 29(12):1023-39. PubMed ID: 26666230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nano-medicine Improving the Bioavailability of Small Molecules for the Prevention of Neurodegenerative Diseases.
    Di Martino P; Censi R; Gigliobianco MR; Zerrillo L; Magnoni F; Agas D; Quaglia W; Lupidi G
    Curr Pharm Des; 2017; 23(13):1897-1908. PubMed ID: 28025942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches.
    Iqbal A; Ahmad I; Khalid MH; Nawaz MS; Gan SH; Kamal MA
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(3):256-84. PubMed ID: 24024521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The active Hsc70/tau complex can be exploited to enhance tau turnover without damaging microtubule dynamics.
    Fontaine SN; Martin MD; Akoury E; Assimon VA; Borysov S; Nordhues BA; Sabbagh JJ; Cockman M; Gestwicki JE; Zweckstetter M; Dickey CA
    Hum Mol Genet; 2015 Jul; 24(14):3971-81. PubMed ID: 25882706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
    Barnham KJ; Bush AI
    Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs.
    Lazarevic-Pasti T; Leskovac A; Momic T; Petrovic S; Vasic V
    Curr Med Chem; 2017; 24(30):3283-3309. PubMed ID: 28685687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders.
    Chong CM; Ai N; Lee SM
    Curr Drug Targets; 2017; 18(4):455-462. PubMed ID: 27033194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.
    Munoz L; Ralay Ranaivo H; Roy SM; Hu W; Craft JM; McNamara LK; Chico LW; Van Eldik LJ; Watterson DM
    J Neuroinflammation; 2007 Sep; 4():21. PubMed ID: 17784957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Barrier function in the peripheral and central nervous system-a review.
    Reinhold AK; Rittner HL
    Pflugers Arch; 2017 Jan; 469(1):123-134. PubMed ID: 27957611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.
    Mattson MP
    Neuromolecular Med; 2003; 3(2):65-94. PubMed ID: 12728191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metallothioneins and the central nervous system: from a deregulation in neurodegenerative diseases to the development of new therapeutic approaches.
    Bolognin S; Cozzi B; Zambenedetti P; Zatta P
    J Alzheimers Dis; 2014; 41(1):29-42. PubMed ID: 24577478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Triazolopyrimidines Are Microtubule-Stabilizing Agents that Bind the Vinca Inhibitor Site of Tubulin.
    Sáez-Calvo G; Sharma A; Balaguer FA; Barasoain I; Rodríguez-Salarichs J; Olieric N; Muñoz-Hernández H; Berbís MÁ; Wendeborn S; Peñalva MA; Matesanz R; Canales Á; Prota AE; Jímenez-Barbero J; Andreu JM; Lamberth C; Steinmetz MO; Díaz JF
    Cell Chem Biol; 2017 Jun; 24(6):737-750.e6. PubMed ID: 28579361
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.